Seller record · Telehealth service

AlyveRx

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. The terms refer only to licensed pharmacies or compounding facilities within the company's Pharmacy Network. 1 more criterion also fails; see the table below.

At a glance

AlyveRxTelehealth service

6/8criteria passed
Price
Semaglutide from $183 a month, tirzepatide from $283
Sells
compounded semaglutide, compounded tirzepatide, and 8 more
FDA letters
None on file
Visit AlyveRxSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide as injections or sublingual drops made with its own delivery technology, with compounded sermorelin, NAD+ and glutathione and the brand drugs Wegovy, Mounjaro and Ozempic. It names no filling pharmacy.

Operating entity Alyve, Inc.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSAlyveRx's website; AlyveRx's terms of service page
S2Prescription gatingPASSAlyveRx's forms storefront; AlyveRx's compounded semaglutide product page
S3Pharmacy identificationFAILAlyveRx's terms of service page; AlyveRx's important safety information page
S4Compounding disclosurePASSAlyveRx's compounded semaglutide product page; AlyveRx's website
S5Analytical documentationFAILAlyveRx's permeact page; AlyveRx's important safety information page
S6Business addressPASSAlyveRx's terms of service page; AlyveRx's notice of privacy practices page
S7Price disclosurePASSAlyveRx's website; AlyveRx's compounded semaglutide product page; AlyveRx's compounded tirzepatide product page; AlyveRx's compounded sermorelin product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider reviews each health assessment and sets the treatment plan, and the terms describe Alyve, Inc. as a managed services organization connecting patients with licensed, independent providers.Source: AlyveRx's website; AlyveRx's terms of service page.
S2PASSEvery eligibility button opens an intake whose first screen says a licensed provider reviews the case before any prescription is issued, and the product pages carry no cart.Source: AlyveRx's forms storefront; AlyveRx's compounded semaglutide product page.
S3FAILThe site names no filling pharmacy. The terms refer only to licensed pharmacies or compounding facilities within the company's Pharmacy Network.Source: AlyveRx's terms of service page; AlyveRx's important safety information page.
S4PASSCompounded medications are not reviewed or approved by the FDA for safety or effectiveness, stated in the answers on the home page and every product page, and the injectable products are named as compounded.Source: AlyveRx's compounded semaglutide product page; AlyveRx's website.
S5FAILNo certificate of analysis or lot document is published on the product pages, the delivery technology page or the safety information and policies.Source: AlyveRx's permeact page; AlyveRx's important safety information page.
S6PASSAlyve, Inc. at a legal address of 17400 Spicewood Way, Mount Dora, FL 32757, printed in the terms, which give 3125 Washington St, Zellwood, FL 32798 as the mailing address. The privacy notice and the safety information print the Zellwood mailing address.Source: AlyveRx's terms of service page; AlyveRx's notice of privacy practices page.
S7PASSCompounded semaglutide from $183 a month and compounded tirzepatide from $283, with semaglutide sublingual drops from $203 and tirzepatide sublingual drops from $249. Compounded sermorelin, NAD+ and glutathione each start at $129 a month, Wegovy at $1,695 and Mounjaro and Ozempic at $1,395 a month.Source: AlyveRx's website; AlyveRx's compounded semaglutide product page; AlyveRx's compounded tirzepatide product page; AlyveRx's compounded sermorelin product page.
S8PASSNo FDA warning letter names AlyveRx or the operating entity Alyve, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, semaglutide sublingual drops, tirzepatide sublingual drops, sermorelin, NAD+, glutathione, Wegovy, Mounjaro, Ozempic.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathione

Unpaid link. AlyveRx does not pay the site, and nothing is earned when it is used. Funding.

Visit AlyveRx

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.